The Pediatric Cancer Genetic Risk Program at Dana-Farber/Boston
Children's provides cancer risk assessment for children, comprehensive
recommendations for managing cancer risk in children, and psychosocial support for
families affected by hereditary cancer. We also conduct research into many
aspects of cancer risk and its management. We are one of the few cancer genetic
risk programs in the U.S. focused specifically on pediatric cancer risk.
Our goal is to help you determine whether your children are at risk of
cancer – and if so, what can be done either to help prevent cancer in your
children or to catch it early and address it quickly for the best possible
We help you manage all aspects of genetic cancer risk – from consideration
of testing to monitoring to counseling. A visit to our program
usually includes time with both a physician and a genetic counselor, both of
whom have expertise in inherited cancer syndromes that affect children. We
are also one of the few programs of this type that includes a pediatric
psychologist who specializes in pediatric hereditary cancer. This
specialized consultation is a standard part of clinic visits offered to each
Our Pediatric Cancer Genetic Risk Program:
We also provide consultation to
community-based providers who may be unfamiliar with the unique medical and psychosocial
issues that arise when a family receives a hereditary cancer diagnosis.
you or your doctor believe your child might have an inherited form of cancer or
be at increased risk for developing cancer – or if you are considering having
children and want to better understand possible risk for your children – you
may wish to schedule an appointment with us.
Our program is recommended for children who have:
The field of genetics is rapidly changing, and we provide advanced options in
genetic testing across the spectrum of new and established inherited cancer
syndromes. The syndromes include, but are not limited to:
Although our Pediatric Cancer Genetic Risk Program is focused on pediatric cancer risk,
adult family members may choose to visit the Dana-Farber Center for Cancer Genetics and Prevention. Both programs work
closely together, allowing us to provide integrated care for families.
Our team includes pediatric oncologists, genetic counselors, psychologists, and other specialists from the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, and the Division of Genetics and Genomics at Boston Children's Hospital.
The core clinical team at Dana-Farber/Boston Children’s includes:
Most cases are reviewed by a larger multidisciplinary team composed of genetic counselors, geneticists, pediatric specialists, psychologists, and oncologists from Dana-Farber and Boston Children’s Hospital. This larger team also forms the basis of expert referrals as needed and includes the following specialists:
In recent years, researchers have made great strides in building our
understanding of how genetic factors influence cancer risk – and how we can
leverage new technologies for testing and screening. At the Pediatric Cancer
Genetic Risk Program, our comprehensive program includes not only the clinical
care of children with cancer but incorporates research at the forefront of
Some of our research interests include:
We offer appointments Monday-Friday. We will work with your
insurance company to obtain coverage; in most cases, insurance companies will
Phone: 617-632-4298Fax: 617-394-2699Email: email@example.com
450 Brookline Avenue
Dana Building, Rm. 3-122
Boston, MA 02215
617-632-2952, or visit our International Patient
Services web section to learn more about our
specialized services for international patients.
U.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.
Genetic testing revealed that Hunter had the same genetic mutation found in his sister Amy.
Precision cancer medicine provides individualized treatment tailored to the specific genetic characteristics of a patient's cancer. Our research and clinical trials are leading the way in precision medicine for pediatric cancer.
Not only are we a top cancer and blood disease center, we're also a top pediatric hospital. Above, our physicians explain how our vast clinical resources benefit patients.